HJ7-20706-49574
3 vaccinations
9 coded responses
31 check-ins
9 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 900 / CA
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
- 2020-12-18
-
2020-12-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2020-12-20
- 2020-12-21
-
2020-12-22
Survey response — days 1–6 daily, dose 1MedDRA: Eye haemorrhage — Feeling: GoodFree text: Blood spot in left eyeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-23
Survey response — days 1–6 daily, dose 1MedDRA: Eye haemorrhage, Musculoskeletal stiffness — Feeling: FairFree text: Stiff neck; blood spot left eyeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-25
- 2021-01-03
-
2021-01-05
Dose 2 — Pfizer-BioNTech
-
2021-01-06
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-06
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities2 call case(s)
- 2021-01-07
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains, Muscle or body aches, NauseaAdult check-in
- 2021-01-11
- 2021-01-12
-
2021-01-20
Survey response — day 14, dose 2MedDRA: Musculoskeletal discomfort, Neck pain — Feeling: GoodFree text: Neck discomfort/painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-26
Survey response — day 21, dose 2MedDRA: Migraine — Feeling: Good · Be unable to do your normal daily activitiesFree text: MigrainesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-02
Survey response — day 28, dose 2MedDRA: Migraine — Feeling: FairFree text: Migraine headachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-09
Survey response — day 35, dose 2MedDRA: Migraine — Feeling: GoodFree text: Persistent migraine headachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-16
- 2021-04-06
-
2021-07-06
Survey response — 6 months, dose 2MedDRA: Hypoaesthesia, Pain in extremity, Paraesthesia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Numbness, tingling and pain of handsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-11-05
Dose 3 — Pfizer-BioNTech
- 2021-11-07
- 2021-11-10
- 2021-11-11
- 2021-11-12
-
2021-11-19
Survey response — day 14, dose 3MedDRA: Cough, Headache, Nasal congestion, Rhinorrhoea — Feeling: FairFree text: Nasal congestion, runny nose, coughing at night, headachesMedDRA releases: 2024-11 · check-in free text available
- 2021-12-03
- 2021-12-12
- 2021-12-17
- 2022-02-04
- 2022-05-06
-
2022-11-05
Survey response — 12 months, dose 3MedDRA: Delivery — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationFree text: Pregnancy with delivery.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-05
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
-
2022-11-07
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-05 | Pfizer-BioNTech | |
| 3 | 2021-11-05 | Pfizer-BioNTech | No |
Call center
3 call center cases
1 successful · 2 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Blood spot in left eye
Systemic reaction (other): Stiff neck; blood spot left eye
Release 2 — day 14, dose 2
Symptoms: Neck discomfort/pain
Release 2 — day 21, dose 2
Symptoms: Migraines
Release 3 — day 28, dose 2
Symptoms: Migraine headaches
Release 3 — day 35, dose 2
Symptoms: Persistent migraine headaches
Release 9 — 6 months, dose 2
Symptoms: Numbness, tingling and pain of hands
Release 10 — day 14, dose 3
Symptoms: Nasal congestion, runny nose, coughing at night, headaches
Release 12 — 12 months, dose 3
Symptoms: Pregnancy with delivery.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Delivery | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hypoaesthesia | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Musculoskeletal discomfort | ✓ | ✓ | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Neck pain | ✓ | ✓ | ✓ |
| SD | Pain in extremity | ✓ | ✓ | ✓ |
| SD | Paraesthesia | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Eye haemorrhage | ✓ | ✓ | ✓ |
| SRO | Musculoskeletal stiffness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release